Objective: A case-control study was conducted to evaluate the effects of diabetes mellitus on serum levels of vitamin A, a-carotene, b-carotene, a-tocopherol, serum and urine RBP. Subjects: One hundred and seven patients with Type 2 diabetes mellitus (28 ± 74 y) were recruited from those attending a primary health care clinic in King Khalid University Hospital in Riyadh City (Saudi Arabia). They were matched for age and sex with 143 healthy individuals. Methods: Fasting blood samples and 10 h urine collections were obtained from all subjects. Levels of vitamins and carotenoids in serum measured by high performance liquid chromatography (HPLC), and of retinol binding protein (RBP) in serum and urine by an enzyme-linked immunosorbent assay (ELISA). Results: The mean serum concentrations of retinol, a-carotene, and a-tocopherol were similar in both groups after correction of lipid soluble vitamins for serum lipids levels. However, serum b-carotene concentration was signi®cantly higher in control subjects than diabetics (P 0.002). Serum and urine RBP concentrations were signi®cantly higher in diabetics than in controls (P 0.0001 ). In normal subjects (but not diabetics) serum concentrations of retinol and RBP were higher in men than in women (P 0.02, P 0.0001 respectively). In both normal and diabetic subjects, serum levels of a-tocopherol (P 0.007) and urine RBP (P 0.005), were higher in men than women. Urinary excretion of RBP was signi®cantly higher in diabetic patients with renal impairment than other diabetics or controls (P 0.0001). There was a negative correlation between fasting blood glucose (FBG) concentration and serum b-carotene (P 0.008) in the total combined group and a positive correlation between FBG and urinary RBPacreatinine (P 0.009) in diabetic patients. Conclusion: Serum b-carotene concentration was signi®cantly lower in diabetic patients than controls. Serum retinol concentration in patients with diabetes was normal, yet serum and urine RBP concentrations were signi®cantly higher in diabetics than in controls. Sponsorship: The research was sponsored by King Faisal Specialist Hospital and Research Center.
Introduction
Earlier studies of the carotenoids and vitamin A in diabetes mellitus have yielded con¯icting results. It has been reported, for example, that individuals with diabetes mellitus have higher blood levels of carotene (Ralli et al, 1936; Murrill et al, 1941; Mosenthal & Loughlin, 1944; Sobel et al, 1953) and lower levels of vitamin A than normal subjects (Mosenthal & Loughlin, 1944) . Ralli et al (1936) postulated that in diabetes mellitus, the conversion of carotene to vitamin A is reduced. However, this suggestion was not supported by the ®nding of a high vitamin A content in the livers of deceased diabetic patients (Moore, 1937) . Several studies have reported that serum levels of both carotene and vitamin A are within normal range in diabetes mellitus (Murrill et al, 1941; Kimble et al, 1946; Ramachandran, 1973) . Recently, an increase in plasma retinyl esters has been reported in Type 2 diabetes (Wako et al, 1986 ) and a decrease in serum concentration of vitamin A and RBP in Type 1 diabetes (Basu et al, 1989) . Other investigators found that retinol concentrations were signi®cantly decreased in Type 1 (Krempf et al, 1991) and increased in Type 2 diabetes mellitus as compared to control subjects (Krempf et al, 1991; Havivi et al, 1991; Sasaki et al, 1995) . Tuitoek et al (1996) reported signi®-cantly lower plasma concentrations of retinol in STZdiabetic Wistar rats which is thought to be a response to diabetes since signi®cantly lower plasma retinol concentrations were also found in pair-feeding and in vitamin A supplemented diabetic rats.
Objective
In the light of such apparent discrepancies, this current study was undertaken to re-evaluate the serum levels of retinol, a-carotene, b-carotene, a-tocopherol, serum and urine RBP in subjects with diabetes mellitus and to compare the results with those in healthy controls, to explore the relationships of these nutrients in patients with diabetes mellitus, and to assess the effect of duration, type and treatment of diabetes on these nutrients.
Materials and methods

Subjects
One hundred and seven Type 2 diabetic patients (aged 28 ± 74 y) were recruited from those attending a diabetic clinic in King Khalid University Hospital (KKUH) in Riyadh City, Saudi Arabia. A group of 143 control subjects, matched for age and sex, were selected after screening 182 apparently healthy subjects. The control subjects were recruited from King Saud University faculty, staff and employees. Their ages ranged from 27 ± 75 y. The controls were selected according to the following criteria based on physical examination and laboratory investigation:
Healthy Saudi males and females; Absence of a family history of diabetes mellitus; Absence of the following: kidney, liver, endocrine, or coronary heart disease; malignant disease; previous surgery on digestive tract, pancreas or biliary system; pregnancy; use of oral contraceptives; physical or mental disability; drug abuse and alcoholism.
All cases were Saudi males or females aged more than 28 y with a diagnosis of diabetes based on a morning fasting blood glucose (FBG) b 7.8mmolal on more than one occasion andaor 2 h after a 75 g oral glucose tolerance test (OGTT) ( ! 200 mgadI; 11.1 mmolaL) (WHO, 1985) Weight and height were measured and body mass index (BMI), BMI wta(ht) 2 ; kgam 2 , was calculated for all subjects.
Methods
A single fasting venous blood sample and a 10 h urine collection were obtained from all subjects. Serum and urine samples were stored at 7 70 C or 7 20 C until analysis. For diabetic patients, details of duration of diabetes, age at onset, family history, use of insulin, type of insulin, and use of hypoglycaemic drugs were recorded. Signed consent form was obtained from patients and controls. Retinol, acarotene, b-carotene and a-tocopherol were analysed by a high pressure liquid chromatography (HPLC) method based on that of Lee et al (1992) with some modi®cations (Abahusam et al, 1998) . Concentrations of RBP in serum and urine were determined using a double antibody sandwich enzyme-linked immunosorbent assay (ELISA) (Lucertini et al, 1984) . Fasting blood glucose, cholesterol and triglycerides were assessed by routine methods (Beckman Synchron Systems, Beckman Instrument Inc., California, USA). Individuals who were taking vitamin or mineral supplements or consuming large amounts of carrots (two cups juice or 1a2 kg of carrots) (2 diabetic patient and 3 control subjects) were excluded from the analysis.
Dietary assessment
The subjects were asked about details of dietary habits with particular stress on frequency of consumption of 35 food group items per day, week, month or year. At the same interview, a complete history (including details of demographic characteristics, socio-economic status, use of medicine and vitamin supplements) was taken from all subjects.
The food frequency questionnaire was used as a rough estimate of the qualitative aspects of the dietary intake. Another technique (24 h recall) was used for the quantitative dietary estimate. However, there was a good correlation (r 0.87) between the two methods. The 24 h energy and nutrient content of dietary intake was calculated using a computerised nutrition analysis system, the Food Processor II (ESHA Research, 1996) . Data were added to the data base for some local and Mediterranean composite dishes (Pellet & Shadarevian, 1970) .
Statistical analysis
Differences between cases and controls, after correction of fat-soluble vitamins for lipid levels, were evaluated by the t-test for unpaired data and the Wilcoxon Rank Sum test. Correlations were computed using Spearman's rank coef®-cient for non parametric data. Chi square contingency table analyses were used to compare the frequency of consumption of individual foods in the two groups. Two-way analysis of variance (ANOVA), t-test (LSD) and Tukey's test were used to assess the effect of sex, diabetes, renal impairment (Renal impairment Serum creatinine b 130 mmolal) and hypertension. Differences were judged to be signi®cant when P values were less than 0.01 to take into accounts the increased probability of a type 1 error because of multiple comparisons. The classic analysis of covariance technique was used to adjust lipid soluble vitamins for lipid levels before comparing overall diabetics and controls. There was no differential relationship in the lipid-vitamin correlation between diabetics and controls. Graphing lipid by vitamins separately for diabetic and controls did not suggest that such a difference exists. All statistical analyses were performed using the Statistical Analysis System (1994) (SAS version 6.09 on a Digital Alpha computer). Results are expressed as mean AE s.d.
Results
Characteristics of cases and controls
Diabetic patients and control individuals were similar in terms of age, weight, body mass index and income. All of the diabetic patients were of type 2 with a mean diabetes duration of 6.9 AE 5.0 y, mean age at onset 43.0 AE 9.6y, and mean daily insulin dose 45.15 AE 21.7 units (Table 1) . Diabetics were treated either by diet alone (n 24), a diet plus oral hypoglycaemic agents (n 70) or treated with insulin (n 13). Table 2 presents the mean 24 h nutrient intake. In general, both groups have similar values in all nutrient variables with the exception of energy and carbohydrate intake, both of which were lower in diabetic patients (P 0.0003 and P 0.0001 respectively). With respect to frequency of consumption of individual foods, control subjects had signi®cantly higher consumption of white bread, rice, spaghetti, butter, cream, vegetable oil, sugar, honey and soft drinks (P 0.0001), while diabetic patients had signi®cantly higher consumption of local dishes made from whole wheat (P 0.0001). It seems likely that the lower re®ned carbohydrate intake by patients with diabetes was probably due to dietary instructions rather than being of any etiologic importance in the pathogenesis of their diabetes.
Dietary intake
Measured variables
Results of vitamins and RBP measurements in serum and urine are shown in Table 3 . The preliminary analysis showed no signi®cant difference in any of these dependent variables among sub-groups of diabetic whether de®ned by treatment groups or duration groups. Therefore, diabetic patients as a single group were compared with controls.
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The fasting concentrations of serum retinol, a-carotene, atocopherol and cholesterol were similar in both groups after correction of lipid soluble vitamins for serum lipids levels. However, the mean serum b-carotene concentration was signi®cantly higher in controls (0.39 AE 0.28umolal; 20.9 AE 15.1 mgadl) than in diabetic patients (0.28 AE 0.22umolal; 14.9 AE 11.8 mgadl) (P 0.002). When compared with controls, diabetic patients had signi®cantly higher concentrations of RBP in serum (45.2 AE 20.5 vs 33.6 AE 15.3 mgal; P 0.0001 ). Urine RBP concentration (expressed either as total amount excreteda10 h or as ratio to creatinine) was signi®cantly higher in diabetic patients (51.7 AE 59.6 mgal) than controls (22.7 AE 2l mgal; P 0.0001). Triglyceride concentrations in serum were signi®cantly higher in diabetic patients (2.0 AE 1.1 mmolaL) than in controls (1.54 AE 0.7 mmolaL; P 0.0001).
Sex differences
When the results were examined according to sex by twoway ANOVA, there was an overall signi®cant sex effect for serum retinol and RBP (P 0.0001, P 0.0007 respectively). However it was also detected that there was a signi®cant interaction (P 0.0007, P 0.04 respectively). This indicates that the direction of the signi®cance is not Retinol, a-tocopherol and carotenoids in diabetes MA Abahusain et al the same for both groups. When a t-test was performed separately for diabetic and control, male control subjects had signi®cantly higher serum concentrations of retinol and RBP than females (P 0.02, P 0.0001 respectively), but there was no signi®cance difference between males and females in the diabetic group. There was an overall signi®cant sex effect in triglycerides (P 0.008), and urine RBP (P 0.005). In the case of these latter parameters there was no signi®cant interaction indicating that the signi®cance is consistent in both groups and in the same direction; men had signi®cantly higher means than women.
Duration, treatment and complication differences There was no relationship between duration since diagnosis of diabetes (`5, 5 ± 10, b 10y) and any of the measured serum nutrients. Mean serum concentrations of a-carotene and retinol were lower in diabetic patients treated with insulin although the decrease was not signi®cant when tested by the t-test for unpaired data or Wilcoxon Rank Sum. However, when a one way ANOVA was performed of urinary RBP on the four groups: controls, diabetic patients, diabetic patients with renal impairment and diabetic patients with hypertension, there was a signi®cance (P 0.0001). This indicates that some differences exist among the groups. To identify which groups differ from each other, Tukey's Studentised Range method was used with a 0.01. It was found that diabetic patients with renal impairment had signi®cantly higher excretion of RBP when compared to other diabetics, to diabetic patients with hypertension, or to controls (Table 4) .
Correlation analysis
There was a signi®cant positive correlation between FBG and urinary RBPacreatinine in diabetic patients (r 0.27, P 0.009) (Figure 1) , and between FBG and serum RBP (r 0.22, P 0.0007) in the diabetic and control groups combined, and a signi®cant negative correlation between FBG and b-carotene (r 7 0.18, P`0.008) in the total combined group. There was a signi®cant positive correlation between serum retinol and serum RBP (r 0.32, P`0.0003) in normal subjects but not in diabetic patients. In the total combined group, retinol correlated well with atocopherol (r 0.3, P 0.0001), serum cholesterol (r 0.3, P 0.0001) and triglycerides (r 0.28, P 0.0001). Beta-carotene correlated well with a-carotene (r 0.68, P 0.0001), and a-tocopherol (r 0.23, P 0.0008). Alpha-tocopherol correlated well in varying degrees of signi®cance with a-carotene (r 0.24, P 0.0008), cholesterol (r 0.55, P 0.0001) and triglycerides (r 0.4, P 0.0001).
Discussion
This study indicates that there is no signi®cant difference in serum retinol concentration between diabetic patients and control subjects in Saudi Arabia. These results agree with the ®ndings of some, but not all, previous published reports. Figure 1 Relationship between FBB (mmolaL) and urinary RBPacreatininea10h in patients with type 2 DM (n 92) (r 0.22; P 0.009). Retinol, a-tocopherol and carotenoids in diabetes MA Abahusain et al
In the USA, Kimble et al (1946) and Murrill et al (l941) observed that vitamin A values in diabetics were similar to those found in non-diabetic subjects. Similar results were found in Type 2 patients in India by Ramachandran (1973) . In recent studies, increased serum retinol concentrations were found in Type 2 diabetes mellitus as compared to control subjects (Krempf et al, 1991; Havivi et al, 1991; Sasaki et al, 1995) . In Type l, low serum levels of vitamin A in up to two-thirds of diabetic patients have been found in an earlier study (Mosenthal & Loughlin, 1944) and other recent studies (Basu et al, 1989; Krempf et al, 1991) . Increased concentrations of RBP both in serum and urine have been reported in both children (Gibb et al, 1989) and adults (Rowe et al, 1987) with diabetes in the absence of either microalbuminuria (Holm et al, 1987) or impaired renal function as assessed by serum creatinine (Holm et al, 1988) . This increase in urinary RBP in diabetic patients with no other evidence of nephropathy may be useful in identifying diabetics at risk for nephropathy. The elevated concentrations of RBP in serum re¯ect the fact that the kidney is the main site for catabolism of RBP. Owing to its small size, RBP is ®ltered at the glomerulus and both reabsorbed and metabolised in the proximal tubule (Smith & Goodman, 1979) . Both reabsorption and catabolism of low molecular weight proteins are impaired in diseases in which there is nephron-loss (Strober & Waldmann, 1974) . Thus, these proteins accumulate in the blood. The simultaneous increase of serum retinol and RBP noted in patients with diabetes support this possibility. Gerlach & Zile (1990) pointed to the possibility that the increased serum retinol observed in nephrectomised rats was due to the increase in retinol associated with RBP coupled with thyroxin binding protein (transthyretin-TTR) and suggested that the hepatic release mechanism is upregulated by lack of renal function. The extent of hepatic up-regulation and increased release of retinol together with RBP and TTR in the circulation depends on readily available liver stores (Gerlach & Zile, 1990) .
The signi®cant correlation between FBG and urine RBP in patients with normal renal function and without microalbuminuria indicate the possibility that poor glycaemic control may result in impaired renal handling of RBP even in the absence of renal disease. Our results are in contrast with those of Basu et al (1989) , who found lower serum RBP levels in 25 type 1 diabetic patients. This observed decrease in RBP levels in Basu and associates' study may be related to the type of diabetes and the possibility that there are differences between Type 1 and Type 2 DM with respect to RBP metabolism. However, although reduced, the RBP concentrations in that study were within the normal range (Basu et al, 1989) .
Published studies re¯ect a clear lack of agreement over the levels of b-carotene in serum in diabetes. Our ®ndings of signi®cantly reduced levels agree with those of Kimble et al (1946) and Ramachandran (1973) , but are in contrast to those reported by other authors (Rabinowitch, 1930; Murrill et al, 1941; Mosenthal & Loughlin, 1944) . A Canadian study in Montreal, Rabinowitch (1930) found that 85% of 1400 diabetic patients studied had total carotene level above the normal limits, while in an American study, 28% of 114 diabetic children had plasma total carotene levels above the normal range with 16% below the normal range (Mosenthal & Loughlin, 1944) . Moreover, Murrill et al (1941) reported that the average total carotene concentration was signi®cantly higher in Type 1 diabetic patients than in normal subjects. Following administration of a large dose of carotene, there was no difference in either the peak blood levels achieved nor in the subsequent rate of decline (Murrill et al, 1941) . This observation was con®rmed by Ramachandran (1973) , and these two studies refute the earlier suggestion that blood carotene levels are higher following an oral dose in diabetes (Ralli et al, 1936) .
Factors that may be responsible for the observed decrease in circulating b-carotene in the diabetic group include:
Malabsorption: this is unlikely since the concentrations of other fat soluble vitamins (retinol and a-tocopherol) were similar in the diabetic and the control groups. Infections: it has been suggested (Kimble, 1946) that chronic infection may result in a decrease in circulating levels of both vitamin A and carotene, possibly due to interference with intestinal absorption (Heymann, 1936) . However, in this current study, there was no signi®cant decline in serum levels of either retinol or bcarotene in diabetic patients with infections when compared to other diabetic patients or control subjects (diagnosis of infection was reported by their physician). Low intake of b-carotene: serum concentration of the pro-vitamin is closely related to dietary intake, falling within a few weeks if the diet is de®cient (Kimble, 1946) . In the present study, there was no signi®cant difference in the 24h carotene intake or frequency consumption of either b-carotene or retinol. Subjects with carotenemia (1 diabetic patient and 3 control subjects) had a history of excessive raw carrot intake and were excluded from the analysis. Low fat diet: absorption of both carotene and vitamin A is in¯uenced by the amount of fat in the diet (Blomhoff et al, 1992) . We found no relationship between serum concentrations of b-carotene and either serum levels or dietary intake of cholesterol and triglycerides. However, there was a signi®cant correlation between serum retinol concentration and both serum cholesterol levels and triglyceride concentrations as well as dietary intake assessed by 24 h recall. In addition, the higher dietary intake of oil butter and cream in control subjects (P 0.0001) may have contributed to their higher levels of serum b-carotene.
In contrast to earlier studies which showed higher serum concentrations of total carotene in diabetic patients, more recent studies suggest that levels of b-carotene may actually be lower in this group. This may re¯ect a change in dietary advice given to people with diabetes. Older recommendations for a low carbohydrate diet inevitably led to a higher intake of fat which may have entrained an increase in intake of fat-soluble vitamins. More recent advice, recommending a high (unre®ned) carbohydrate diet may have reversed this trend.
Discrepancies between older and more recent studies may also be attributable to differences in analytical methodology. In earlier studies, all carotene content present in plasma was determined either by methods based on colour comparison with a standard (oleic acid) (Rabinowitch, 1930) , or by using the Carr ± Price reaction in which measurements were made of total retinol and carotene content, followed by subtraction of the carotene value as determined by colorimetric analysis (Mosenthal & Loughlin, 1944) . Differences between these older methods and modern HPLC methods clearly make comparison of results extremely dubious.
The importance of the A and E groups of vitamins in diabetes may relate to their antioxidant properties. Although the precise mechanism of many of the complications of diabetes is unknown, it is increasingly believed that oxidative tissue damage may play a role in their pathogenesis. Beta-carotene has been reported to be a potent free radical quencher, singlet oxygen scavenger and lipid antioxidant (Burton & Ingold, 1984; Krinsky, 1993) ; it is possible that the reduced serum concentrations of b-carotene in diabetic patients may be due to its depletion as a sacri®ced antioxidant (Bendich & Olson, 1989 ).
An alternative explanation is that in diabetes, there is an increased production of singlet oxygen for which b-carotene is the scavenger. In other diseases with increased production of oxygen free radicals, such as cystic ®brosis or renal failure, b-carotene was the most severely depressed antioxidant (Favier et al, 1994) . However, the fact that the concentration of a-tocopherol, the other antioxidant studied, was not reduced in diabetic subjects does not lend support to this possibility, although it has been shown that there are situations (such as HIV infection) in which there is predominant suppression of b-carotene compared with other antioxidants such as tocopherol, zinc and selenium (Favier et al, 1994) .
Conclusion
This study indicated that levels of b-carotene may be reduced in patients with diabetes and that there is a negative correlation between b-carotene and glycaemic control as assessed by fasting blood glucose. Whether bcarotene should be considered as a therapeutic agent in diabetes requires further studies.
The present data indicated a rise in both serum and urine RBP levels in patients with renal impairment and in diabetic patients with no other evidence of renal impairment. This ®nding may be useful in identifying diabetics at risk of nephropathy.
